Who Paid My Doc
Collagenase Santyl
Drug Pharma Product
NDC 50484-010-30
General payments
$517,209
Research payments
$109,458
Through program year 2021, $517,209 in general payments and $109,458 in research payments were reported against Collagenase Santyl (Pharma Product).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $517,209 | 15,703 |
| 2021 | Research | $109,458 | 4 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 112 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
15,703 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.